Abstract
Molecular cloning has revealed that erythroid potentiating activity (EPA) and tissue inhibitor of metalloproteinases (TIMP) represent two distinct activities of a single protein. We have studied the expression of the EPA/TIMP gene at the mRNA and protein levels during 12-O-tetradecanoyl-phorbol-13-acetate (TPA)-induced megakaryoblastic differentiation of K562 human chronic myeloid leukemia cells. Northern hybridization analysis showed that the EPA/TIMP mRNA was increased within 3 hours of TPA-induction and reached maximal levels (about 50-fold induction) during the first day of treatment. The expression of mRNAs for two major metalloproteinases, collagenase-I and stromelysin, were activated in parallel in the differentiation-induced K562 cells. The increase of EPA/TIMP mRNA correlated with increased EPA/TIMP protein biosynthesis and secretion: the TPA-induced cells secreted substantially enhanced amounts of metabolically labeled proteins, of which EPA/TIMP represented up to 50% after the first day of treatment (over 100-fold induction). The induction of EPA/TIMP mRNA was associated with its increased transcription. EPA/TIMP induction required continuous protein synthesis, being completely inhibited by addition of the protein synthesis inhibitor cycloheximide simultaneously with TPA, but only partially inhibited in a time-dependent manner if cycloheximide was added after TPA. Unlike in other cells tested, the jun and c-fos transcription factor mRNAs showed a prolonged biphasic induction response in K562 cells during TPA treatment. This response was associated with enhanced activity of a transfected recombinant reporter plasmid containing binding sites for the jun/fos transcription factor complex (AP-1) similar to the TPA-responsive element (TRE) sequence we found in the EPA/TIMP gene promoter. We suggest that the induction of EPA/TIMP and several other genes specific for the differentiating K562 cells may be a consequence of the sustained activation of immediate early genes encoding transcription factors, such as jun and c-fos.
Original language | English |
---|---|
Pages (from-to) | 1974–1982 |
Number of pages | 9 |
Journal | Blood |
Volume | 75 |
Issue number | 10 |
Publication status | Published - 15 May 1990 |
MoE publication type | A1 Journal article-refereed |
Keywords
- Cell Line
- Cell Transformation, Neoplastic/drug effects
- DNA-Binding Proteins/genetics
- Gene Expression/drug effects
- Glycoproteins/genetics
- Humans
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive/metabolism
- Lymphokines/genetics
- Microbial Collagenase/antagonists & inhibitors
- Protein Biosynthesis
- Proto-Oncogene Proteins/genetics
- Proto-Oncogene Proteins c-fos
- Proto-Oncogene Proteins c-jun
- RNA, Messenger/genetics
- Tetradecanoylphorbol Acetate/pharmacology
- Tissue Inhibitor of Metalloproteinases
- Transcription Factors/genetics